Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Pathologic Complete Response × Colonoscopy × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 72 Colonic Neoplasms 26 Colonic Polyps 17 Adenoma 14 Neoplasms 7 Polyps 6 Adenomatous Polyps 6 Disease 5 Colorectal Neoplasms, Hereditary Nonpolyposis 5 Pain 4 Rectal Neoplasms 3 Gastrointestinal Neoplasms 3 Stomach Neoplasms 2 Peptic Ulcer 2 Pancreatic Neoplasms 2 Liver Cirrhosis 2 Intestinal Diseases 2 Inflammatory Bowel Diseases 2 Gastritis, Atrophic 2 Digestive System Diseases 2 Colitis, Ulcerative 2 Anus Neoplasms 2 Turcot syndrome 1 Tuberculosis 1 Triple Negative Breast Neoplasms 1 Signs and Symptoms, Digestive 1 Recurrence 1 Rectal Diseases 1 Predictive Cancer Model 1 Personal Satisfaction 1

Interventions

Trastuzumab 6 Carboplatin 6 Docetaxel 5 Paclitaxel 4 Oxaliplatin 4 Fluorouracil 4 Cytarabine 4 Cyclophosphamide 4 Azacitidine 4 pertuzumab 3 pembrolizumab 3 Radiotherapy 3 Observation 3 Epirubicin 3 Endoscopy 3 Cisplatin 3 Chemoradiotherapy 3 Capecitabine 3 venetoclax 2 sargramostim 2 olaparib 2 durvalumab 2 cc-486 2 Surgical Procedures, Operative 2 Standard of Care 2 Pemetrexed 2 Neoadjuvant Therapy 2 Monatide (IMS 3015) 2 Magnetic Resonance Imaging 2 Leucovorin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07472868 2026-03-16

MEND-IT II

Catharina Ziekenhuis Eindhoven

Phase 3 Not yet recruiting

Pathologic Complete Response

Data powered by HemOnc (CC BY 4.0) Colophon ⚡